Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 5
Submit an article Journal homepage
1,091
Views
14
CrossRef citations to date
0
Altmetric
Author's View

Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1

Erika VacchelliGustave Roussy Cancer Campus, Villejuif, France;INSERM, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Yuting MaGustave Roussy Cancer Campus, Villejuif, France;INSERM, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France;Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China;Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
,
Elisa E. BaraccoGustave Roussy Cancer Campus, Villejuif, France;INSERM, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France
,
Laurence ZitvogelGustave Roussy Cancer Campus, Villejuif, France;Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France;INSERM, Villejuif, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT)507, Villejuif, France
&
Guido KroemerGustave Roussy Cancer Campus, Villejuif, France;INSERM, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France;Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected]
Article: e1118600 | Received 04 Nov 2015, Accepted 04 Nov 2015, Published online: 22 Apr 2016

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Vincent Carbonnier, Julie Le Naour, Thomas Bachelot, Erika Vacchelli, Fabrice André, Suzette Delaloge & Guido Kroemer. (2023) Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer. OncoImmunology 12:1.
Read now
Julie Le Naour, Zsofia Sztupinszki, Vincent Carbonnier, Odile Casiraghi, Virginie Marty, Lorenzo Galluzzi, Zoltan Szallasi, Guido Kroemer & Erika Vacchelli. (2022) A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients. OncoImmunology 11:1.
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Toll-like receptor agonists in cancer immunotherapy. OncoImmunology 7:12.
Read now
Nella Prevete, Federica Liotti, Anna Illiano, Angela Amoresano, Piero Pucci, Amato de Paulis & Rosa Marina Melillo. (2017) Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways. OncoImmunology 6:4.
Read now
Elisa E. Baracco, Federico Pietrocola, Aitziber Buqué, Norma Bloy, Laura Senovilla, Laurence Zitvogel, Erika Vacchelli & Guido Kroemer. (2016) Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. OncoImmunology 5:6.
Read now

Articles from other publishers (8)

Juliette Humeau, Julie Le Naour, Guido Kroemer & Jonathan G. Pol. 2023.
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N. Fukuda & Chikara Ohyama. (2021) Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy. BMC Cancer 21:1.
Crossref
Shu-Fen Chiang, Kevin Chih-Yang Huang, William Tzu-Liang Chen, Tsung-Wei Chen, Tao-Wei Ke & K. S. Clifford Chao. (2021) Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Cancer Immunology, Immunotherapy 70:10, pages 2937-2950.
Crossref
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi R. Madiyalakan, Yolanda D. Mahnke & Christopher Nicodemus. (2020) Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients. Cancer Immunology, Immunotherapy 69:3, pages 383-397.
Crossref
Bin Ke, Ting Wei, Yuanyuan Huang, Yuxin Gong, Gang Wu, Junfang Liu, Xiaoting Chen & Lin Shi. (2019) Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2. Mediators of Inflammation 2019, pages 1-17.
Crossref
Georgina J. Clark, Pablo A. Silveira, P. Mark Hogarth & Derek N.J. Hart. (2019) The cell surface phenotype of human dendritic cells. Seminars in Cell & Developmental Biology 86, pages 3-14.
Crossref
Xue Jiang, Ting Lei & Man Zhang. (2018) Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer. Technology in Cancer Research & Treatment 17, pages 153303461876941.
Crossref
Qi-Xiang Li, Gerold Feuer, Xuesong Ouyang & Xiaoyu An. (2017) Experimental animal modeling for immuno-oncology. Pharmacology & Therapeutics 173, pages 34-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.